The ability of Graves' disease patients with the +32204 GG genotype to fully methylate their DNA may correlate with the methylation levels of interleukin-1beta (IL-1β) and transforming growth factor-beta (TGF-β) promoter regions, impacting IL-1β and TGF-β production.105. The gene discussed is TGFB1; the disease is Graves disease.